CMA hails new draft leg­is­la­tion

Pharmacy Daily - - NEWS -

COM­PLE­MEN­TARY Medicines Aus­tralia (CMA) has wel­comed the re­lease of the “ex­po­sure draft” of the Ther­a­peu­tic Goods Amend­ment (2017 Mea­sures No. 1) Bill 2017 which in­cludes amend­ments to pro­vide a new ap­proval path­way for list­ing com­ple­men­tary medicines with higher ther­a­peu­tic in­di­ca­tions and health claims.

CMA ceo Carl Gib­son said the mea­sure aimed to re­ward greater in­vest­ment in R D by in­dus­try, pro­vid­ing an in­cen­tive to fur­ther ex­pand the clin­i­cal re­search base for com­ple­men­tary medicines.

He said the use of tra­di­tional and com­ple­men­tary medicines (CMs) is grow­ing world­wide, with a sup­port­ive busi­ness en­vi­ron­ment set to help the Aus­tralian CM sec­tor con­tinue its rapid growth, sup­port lo­cal in­no­va­tion-rich man­u­fac­tur­ing and Aus­tralian based re­search.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.